The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - AstraZeneca; Bristol-Myers Squibb; MedImmune; Merck; Pfizer
Updated safety and clinical activity of durvalumab monotherapy in previously treated patients with stage IIIB/IV NSCLC.
 
Ani Sarkis Balmanoukian
Speakers' Bureau - BMS Brazil; Genentech; Merck
Research Funding - Genentech; Incyte; MedImmune; Merck; Merck Serono
 
Scott Joseph Antonia
Stock and Other Ownership Interests - Cellular Biomedicine Group
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
 
Wen-Jen Hwu
Consulting or Advisory Role - Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MedImmune; Merck/Schering Plough
 
Omid Hamid
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Novartis; Roche
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Genentech; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Genentech (Inst); Immunocore (Inst); Incyte (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Novartis (Inst); Pfizer (Inst); Rinat (Inst); Roche (Inst)
 
Martin Gutierrez
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bayer; Karyopharm Therapeutics; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Foundation One Inc; Merck
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Rahima Jamal
No Relationships to Disclose
 
Guy Heinrich Maria Jerusalem
Honoraria - Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Novartis; Pfizer; Roche
Research Funding - Novartis; Roche
Travel, Accommodations, Expenses - Novartis; Roche
 
Myung-Ju Ahn
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; MSD; Ono Pharmaceutical; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck; MSD; Ono Pharmaceutical; Roche
 
Dong-Wan Kim
No Relationships to Disclose
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
Sang-We Kim
No Relationships to Disclose
 
Julie R. Brahmer
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Lilly; Merck; Syndax
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck
Other Relationship - Bristol-Myers Squibb; merck
 
Jose Lutzky
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Novartis; Pfizer
Speakers' Bureau - Bristol-Myers Squibb; Novartis
Research Funding - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Elios Pharmaceutical; Genentech/Roche; Incyte; Merck; Merck Serono; Novartis; Pfizer; Viralytics
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Pfizer
 
Jared Weiss
Consulting or Advisory Role - AstraZeneca; Biodesix; EMD Serono; Genentech; Lilly; OncoPlex Diagnostics
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Celgene (Inst); Merck (Inst); novartis (Inst); Pfizer (Inst)
 
Xiaoping Jin
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Joyce Antal
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca
 
Ashok Kumar Gupta
Employment - MedImmune
Stock and Other Ownership Interests - AstraZeneca; Bristol-Myers Squibb
 
Neil Howard Segal
Honoraria - MedImmune
Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Calithera Biosciences; Imugene; Kyocera; Macrogenics; Pfizer; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Pfizer; Roche/Genentech